Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2561]

Role of family history and genetic testing in diagnosis

Dr Marie Wood – University of Vermont, Burlington, USA

Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )

Regorafenib effective for GISTs that progress due to resistance to approved...

Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )

ASCO 2012: Advances in myeloma

Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof...

ASCO 2012: Advances in myeloma ( Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof Gareth Morgan - Royal Marsden Hospital, UK )

Problems in the structure of clinical trials

Prof Thomas Tursz – Institut Gustave Roussy, Paris, France

Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )

New approaches to personalised medicine

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany

New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )

Heterogeneity of tumours and the challenges of biomarker development

Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy

Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )

Cancer genes differ in different parts of a tumour

Prof Charles Swanton - CRUK London Research Institute and UCL, UK

Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )

Targeting DNA damage response and repair excluding PARP for triple negative...

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )

Endocrine therapy resistance and next generation sequencing

Prof Matthew Ellis - Washington University, USA

Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada

Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Prof Richard Finn - Universtity of California, Los Angeles, USA

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )

Metabolism in malignant tumors: a new approach for treating breast cancer

Prof Tak Mak - University of Toronto, Canada

Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )

More from ecancer